Neuropathology and Applied Neurobiology

Papers
(The median citation count of Neuropathology and Applied Neurobiology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Neuronal infection is a major pathogenetic mechanism and cause of fatalities in human acute Nipah virus encephalitis111
Oral Abstracts60
Editorial58
An autopsy case of late‐onset spinocerebellar atrophy type 1451
Intelligence quotient–genotype association in dystrophinopathies: A systematic review and meta‐analysis44
Novel naturally occurring autoantibodies attenuate α‐synuclein pathology in a mouse model of Parkinson's disease40
Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies30
29
Paediatric astroblastoma‐like neuroepithelial tumour of the spinal cord with a MAMLD1‐BEND2 rearrangement29
Author Index29
Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis29
Response letter: Complexities in pericyte markers28
28
Erratum26
Issue Information26
Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity25
A novel SREBF1::NACC1 gene fusion in an unclassifiable intracranial tumour25
Rapid bacterial identification from formalin‐fixed paraffin‐embedded neuropathology specimens using 16S rDNA nanopore sequencing24
Neuronal and astrocytic tetraploidy is increased in drug‐resistant epilepsy24
Analysing cerebrospinal fluid with explainable deep learning: From diagnostics to insights23
124th Meeting of the British Neuropathological Society The View, Royal College of Surgeons of England, Lincoln's Inn Fields, London21
Cover Image, Volume 50, Issue 321
Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10 + 16 mutation21
The S1PR2‐CCL2‐BDNF‐TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia21
Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types21
A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia21
20
Balloon cells promote immune system activation in focal cortical dysplasia type 2b20
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology19
Genetic inhibition of PDK1 robustly reduces plaque deposition and ameliorates gliosis in the 5×FAD mouse model of Alzheimer's disease18
Perineuronal nets are phagocytosed by MMP‐9 expressing microglia and astrocytes in the SOD1G93A ALS mouse model18
Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel–Lindau disease‐related tumours18
Non‐coding regulatory elements: Potential roles in disease and the case of epilepsy17
Impaired brain insulin signalling in Parkinson's disease17
16
Phenotypic and epigenetic heterogeneity in FGFR2‐fused glial and glioneuronal tumours15
Image‐based deep learning reveals the responses of human motor neurons to stress and VCP‐related ALS15
Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS‐mutant neurocutaneous melanosis14
Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue14
RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery14
Fibrodysplasia ossificans progressiva: Histopathological implications of aberrant bone morphogenic protein signalling for CNS dysgenesis14
Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges14
Microglia induce an interferon‐stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide14
Adult‐onset Alexander disease with unusual inflammatory features and a novel GFAP mutation in two patients14
The autophagy‐enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado–Joseph disease14
Systematic review of human post‐mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease14
Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality‐dependent prognostic patterns13
Robust methylation‐based classification of brain tumours using nanopore sequencing13
The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases13
m6A mRNA methylation in human brain is disrupted in Lewy body disorders13
TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models13
126th Meeting of the British Neuropathological Society The View, Royal College of Surgeons of England, Lincoln's Inn Fields, London12
Neurodegenerative movement disorders: An epigenetics perspective and promise for the future12
Is islet amyloid polypeptide indeed expressed in the human brain?12
Issue Information12
WNT‐activated, MYC‐amplified medulloblastoma displaying intratumoural heterogeneity12
Neurotherapeutic implications of sense and respond strategies generated by astrocytes and astrocytic tumours to combat pH mechanical stress12
Hippocampal dentate granule cells in temporal lobe epilepsy: A morphometry and transcriptomic study12
MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis12
12
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies12
The blood–CSF–brain route of neurological disease: The indirect pathway into the brain12
12
Interferon‐gamma contributes to disease progression in the Ndufs4(−/−) model of Leigh syndrome11
Issue Information11
Muscle biopsy practices in the evaluation of neuromuscular disease: A systematic literature review11
Fibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?11
Issue Information11
Corrigendum11
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis11
Intramuscular Nerve Bundles Reflect TDP‐43 Pathology in the Medulla and Spinal Cord of ALS Patients11
Nanopore sequencing identifies Borrelia miyamotoi as an unexpected cause of meningitis after B cell depletion11
Pathological Characterisation of Posterior Cortical Atrophy in Comparison With Amnestic Alzheimer's Disease10
AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD536310
10
Corrigendum9
Atypical teratoid/rhabdoid tumour‐TYR subtype arising in the setting of germline ring chromosome 22: An uncommon form of tumour predisposition9
Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains9
9
Ageing‐related tau astrogliopathy severely affecting the substantia nigra9
HnRNP K mislocalisation in neurons of the dentate nucleus is a novel neuropathological feature of neurodegenerative disease and ageing9
Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC9
9
Quantitative cellular changes in multiple system atrophy brains9
Letter to the editor8
Proteomic profiling of polyglucosan bodies associated with glycogenin‐1 deficiency in skeletal muscle8
GFAP expression in the brain during human postnatal development8
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment8
Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease8
Cytoplasmic HDAC4 recovers synaptic function in the 3×Tg mouse model of Alzheimer's disease8
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review7
Issue Information7
LMNB1‐duplication mediated nuclear architecture alteration and demyelination of cerebral white matter in a patient with ADLD7
Issue Information7
Adult brain tumour research in 2024: Status, challenges and recommendations7
Correlations in post‐mortem imaging‐histopathology studies of sporadic human cerebral small vessel disease: A systematic review7
Expression pattern of perilipins in human brain during aging and in Alzheimer's disease7
Cerebellar phenotypes in germline PTEN mutation carriers7
Regulation of CNS pathology by Serpina3n/SERPINA3: The knowns and the puzzles7
Regional redistribution of CB1 cannabinoid receptors in human foetal brains with Down's syndrome and their functional modifications in Ts65Dn+/+ mice7
Soluble amyloid‐β dimers are resistant to amyloid‐β prion conversion in vivo suggesting antiprion properties7
CD8 T‐cell‐mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer7
Identification of a novel heterozygous DYSF variant in a large family with a dominantly‐inherited dysferlinopathy6
6
Cover Image, Volume 50, Issue 16
Ectopic expression of neuronal adenosine kinase, a biomarker in mesial temporal lobe epilepsy without hippocampal sclerosis6
TAF15 and Transportin 1 in Intranuclear Inclusions of Neuronal Intranuclear Inclusion Disease6
Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies6
Multiplex Immunofluorescent Analysis of Alpha‐Synuclein in Nigral Lewy Bodies With Heat‐Induced Antibody Stripping Reveals an Intricate Multilayered Structure6
Issue Information6
Phosphorylation of MAP 1A regulates hyperphosphorylation of Tau in Alzheimer's disease model6
A novel homozygous nonsense variant in COL12A1 causes myopathic Ehlers‐Danlos syndrome: A case report and literature review6
Mechanisms of COVID‐19‐associated olfactory dysfunction6
125th Meeting of the British Neuropathological Society The View, Royal College of Surgeons of England, Lincoln's Inn Fields, London6
Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy6
Artificial intelligence in histopathological image analysis of central nervous system tumours: A systematic review6
Cortical morphometric vulnerability to generalised epilepsy reflects chromosome‐ and cell type‐specific transcriptomic signatures5
Classification of diseases with accumulation of Tau protein5
5
Refining Muscle Morphometry Through Machine Learning and Spatial Analysis5
Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high‐grade gliomas5
Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognisable by a specific epigenetic signature5
5
Psychotic symptoms in frontotemporal dementia with TDP‐43 tend to be associated with type B pathology5
PLAG‐Family Amplified CNS Embryonal Tumour With PLAG1 Immunohistochemical Expression: Expanding the Spectrum of Diagnostic Tools5
Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH‐mutant and 1p/19q‐codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case r5
Distinguishing post‐translational modifications in dominantly inherited frontotemporal dementias: FTLD‐TDP Type A (GRN) vs Type B (C9orf72)5
Computational Analysis of SOD1‐G93A Mouse Muscle Biomarkers for Comprehensive Assessment of ALS Progression5
Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options5
Issue Information4
Muscleblind‐like 2 knockout shifts adducin 1 isoform expression and alters dendritic spine dynamics of cortical neurons during brain development4
A TOR1AIP1 variant segregating with an early onset limb girdle myasthenia—Support for the role of LAP1 in NMJ function and disease4
Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis4
4
Skeletal muscle involvement in systemic amyloidosis is often overlooked4
The molecular mechanisms that underlie IGHMBP2‐related diseases4
Cover Image, Volume 48, Issue 54
Respiratory chain dysfunction in perifascicular muscle fibres in patients with dermatomyositis is associated with mitochondrial DNA depletion4
Neuroinvasion via Peripheral Nerves in Epidemic Viral Encephalitis Caused by Enterovirus, Orthoflavivirus and SARS‐Coronavirus4
Pathological substrate of memory impairment in multiple system atrophy4
Long‐standing multiple system atrophy‐Parkinsonism with limbic and FTLD‐type α‐synuclein pathology4
4
4
3
A systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies3
3
Change in the molecular properties of CH1641 prions after transmission to wild‐type mice: Evidence for a single strain3
Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification3
Issue Information3
What to do with unusual TDP‐43 proteinopathy cases?3
Testing Meningiomas With Methylation Arrays: Insights and Recommendations From a Large Single‐Centre Study3
Chronic traumatic encephalopathy neuropathologic change in former Australian rugby players3
Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease3
Paths to hippocampal damage in neuromyelitis optica spectrum disorders3
Oxygen treatment reduces neurological deficits and demyelination in two animal models of multiple sclerosis3
3
Diffuse infiltrating tumour with the molecular profile of an atypical teratoid rhabdoid tumour (AT/RT SHH‐1B) in an adult patient3
Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation3
Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy2
CuII(atsm) significantly decreases microglial reactivity in patients with sporadic amyotrophic lateral sclerosis2
Genotype–Phenotype Correlation in Progressive External Ophthalmoplegia: Insights From a Retrospective Analysis2
Expression, prognostic significance and therapeutic implications of PD‐L1 in gliomas2
2
Olfactory bulb SARS‐CoV‐2 infection is not paralleled by the presence of virus in other central nervous system areas2
A reassessment of spinal cord pathology in severe infantile spinal muscular atrophy2
Nanoscale reorganisation of synaptic proteins in Alzheimer's disease2
The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review2
Investigating key factors underlying neurodegeneration linked to alpha‐synuclein spread2
Progressive hemispheric atrophy in HIV: A Rasmussen's‐like variant of CD8 encephalitis?2
TAPPing into the potential of inducible tau/APP transgenic mice2
Pathogenic variants of Valosin‐containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells2
ALK‐rearranged histiocytosis: Report of two cases with involvement of the central nervous system2
Slow disease progression and characteristic TDP‐43 inclusions in a patient with familial amyotrophic lateral sclerosis carrying a TARDBP G357S variant2
A high‐throughput single‐cell RNA expression profiling method identifies human pericyte markers2
Post‐mortem 7T MR imaging and neuropathology in middle stage juvenile‐onset Huntington disease: A case report2
Tuberous sclerosis complex‐1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's disease2
0.081311225891113